Bioretec Receives CMS Pass-Through Payment for the US Market →
logo
logo
  • Home
  • Products
  • Company
  • News
  • Contact
  • Activa
  • RemeOs™
  • Investors

Clinical and Technical Publications

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Recent Posts

  • Correction: The Board of Directors of Bioretec Ltd resolved on a new stock option plan
  • Inside information: Chief Financial Officer Tuukka Paavola will leave the company
  • Bioretec appoints Conan Cavanagh as Head of Research & Development and member of the Management Team
  • Bioretec appoints Conan Cavanagh as Head of Research & Development and member of the Management Team
  • Bioretec concludes change negotiations

Recent Comments

No comments to show.

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023

Categories

  • Press Release
  • Clinical and Technical Publications
Better healing –  better life

Products

Product overviewActivaRemeOs

About Bioretec

CompanyCareersNews & EventsStoriesSales & Marketing Hub

Financials

InvestorsTerms and Conditions of Sale

Connect

ContactDistributors

Newsletter

 
 

Sign up to receive updates on Bioretec’s webinars, events, publications, and products. By subscribing, you agree to our privacy policy.

© Bioretec. All rights reserved. Specifications are subject to change without notice.

Privacy Policy
Cookies